Expert review of respiratory medicine · 2026
Health disparities in cystic fibrosis in the context of the exposome: recent developments and future directions.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oates Gabriela R, Stephens Crystal, Schechter Michael S
Аннотация
INTRODUCTION: Clinical outcomes with cystic fibrosis (CF) vary substantially even among individuals with the same cystic fibrosis transmembrane conductance regulator (CFTR) genotype due to the wide spectrum of exposures that are linked to the social determinants of health.
AREAS COVERED: The exposome framework offers a comprehensive lens to understand the non-genetic contributors to CF variability and the mechanisms by which sociodemographic characteristics impact upon health. It provides a structured approach to studying the effects of the natural, built, social, and policy environments on CF outcomes, as well as their internal biological effects.
EXPERT OPINION: Integrating exposome science with multi-omics and clinical data promises to advance precision medicine, improve risk prediction, and reduce health disparities in CF. Addressing the challenges of exposome research will require multidisciplinary collaboration, innovative methodologies, and a commitment to translating findings into equitable clinical care.
AREAS COVERED: The exposome framework offers a comprehensive lens to understand the non-genetic contributors to CF variability and the mechanisms by which sociodemographic characteristics impact upon health. It provides a structured approach to studying the effects of the natural, built, social, and policy environments on CF outcomes, as well as their internal biological effects.
EXPERT OPINION: Integrating exposome science with multi-omics and clinical data promises to advance precision medicine, improve risk prediction, and reduce health disparities in CF. Addressing the challenges of exposome research will require multidisciplinary collaboration, innovative methodologies, and a commitment to translating findings into equitable clinical care.